Evidence map›Paper›PMID 33908710›Full record

ArticleJournal of gynecologic oncology2021

Paraaortic sentinel lymph node detection in intermediate and high-risk endometrial cancer by transvaginal ultrasound-guided myometrial injection of radiotracer (TUMIR).

Martina Aida Angeles, Federico Migliorelli, Sergi Vidal-Sicart, Adela Saco, Jaume Ordi, Cristina Ros, Pere Fusté, Meritxell Munmany, Sílvia Escura, Núria Carreras and 5 more

Open access · diamondAbstract read
In one paragraph

Article in Journal of gynecologic oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Martina Aida Angeles *Institute Clinic of Gynecology, Obstetrics, and Neonatology, Hospital Clínic of Barcelona, Spain.ORCID 0000-0003-4401-3084
Federico Migliorelli *Department of Gynecology and Obstetrics, Centre Hospitalier Intercommunal des Vallées de l'Ariège, St. Jean de Verges, France.ORCID 0000-0002-2185-369X
Sergi Vidal-SicartDepartment of Nuclear Medicine, Hospital Clínic of Barcelona, Spain.ORCID 0000-0002-6303-3606
Adela SacoInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.ORCID 0000-0001-9935-9045
Jaume OrdiFaculty of Medicine, University of Barcelona, Barcelona, Spain.ORCID 0000-0002-4820-7954
Cristina RosInstitute Clinic of Gynecology, Obstetrics, and Neonatology, Hospital Clínic of Barcelona, Spain.ORCID 0000-0003-0455-6420
Pere FustéInstitute Clinic of Gynecology, Obstetrics, and Neonatology, Hospital Clínic of Barcelona, Spain.ORCID 0000-0002-8129-9897
Meritxell MunmanyInstitute Clinic of Gynecology, Obstetrics, and Neonatology, Hospital Clínic of Barcelona, Spain.ORCID 0000-0003-4435-1542
Sílvia EscuraInstitute Clinic of Gynecology, Obstetrics, and Neonatology, Hospital Clínic of Barcelona, Spain.ORCID 0000-0003-4423-3650
Núria CarrerasInstitute Clinic of Gynecology, Obstetrics, and Neonatology, Hospital Clínic of Barcelona, Spain.ORCID 0000-0002-4809-8102
Nuria Sánchez-IzquierdoDepartment of Nuclear Medicine, Hospital Clínic of Barcelona, Spain.ORCID 0000-0002-8565-1552
Jaume PahisaInstitute Clinic of Gynecology, Obstetrics, and Neonatology, Hospital Clínic of Barcelona, Spain.ORCID 0000-0003-0262-8320
Aureli TornéInstitute Clinic of Gynecology, Obstetrics, and Neonatology, Hospital Clínic of Barcelona, Spain.ORCID 0000-0003-4700-9507
Pilar ParedesDepartment of Nuclear Medicine, Hospital Clínic of Barcelona, Spain.ORCID 0000-0002-8097-9217
Marta Del PinoInstitute Clinic of Gynecology, Obstetrics, and Neonatology, Hospital Clínic of Barcelona, Spain.ORCID 0000-0003-2178-2403
Hospital Clínic de Barcelona · ESHôpital Intercommunal de Créteil · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveWe aimed to evaluate the accuracy of sentinel lymph node (SLN) mapping with transvaginal ultrasound-guided myometrial injection of radiotracer (TUMIR) to detect lymph node (LN) metastases, in patients with intermediate and high-risk endometrial cancer (EC), focusing on its performance to detect paraaortic involvement.

methodsProspective study including women with preoperative intermediate or high-risk EC, according to ESMO-ESGO-ESTRO consensus, who underwent SLN mapping using the TUMIR approach. SLNs were preoperatively localized by planar and single photon emission computed tomography/computed tomography images, and intraoperatively by gamma-probe. Immediately after SLN excision, all women underwent systematic pelvic and paraaortic lymphadenectomy by laparoscopy.

resultsThe study included 102 patients. The intraoperative SLN detection rate was 79.4% (81/102). Pelvic and paraaortic drainage was observed in 92.6% (75/81) and 45.7% (37/81) women, respectively, being exclusively paraaortic in 7.4% (6/81). After systematic lymphadenectomy, LN metastases were identified in 19.6% (20/102) patients, with 45.0% (9/20) showing paraaortic involvement, which was exclusive in 15.0% (3/20). The overall sensitivity and negative predictive value (NPV) of SLNs by the TUMIR approach to detect lymphatic involvement were 87.5% and 97.0%, respectively; and 83.3% and 96.9%, for paraaortic metastases. After applying the MSKCC SLN mapping algorithm, the sensitivity and NPV were 93.8% and 98.5%, respectively.

conclusionThe TUMIR method provides valuable information of endometrial drainage in patients at higher risk of paraaortic LN involvement. The TUMIR approach showed a detection rate of paraaortic SLNs greater than 45% and a high sensitivity and NPV for paraaortic metastases in women with intermediate and high-risk EC.

Indexed as

Endometrial NeoplasmsSentinel Lymph NodeFemaleHumansLymph Node ExcisionLymph NodesNeoplasm StagingProspective StudiesSentinel Lymph Node BiopsyUltrasonography, InterventionalEndometrial NeoplasmsGenital Neoplasms, FemaleLymph Node ExcisionSensitivity and SpecificitySentinel Lymph NodeSurgery

Identifiers

PMID33908710
PMCPMC8192237
OpenAlexW3145036742

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.